Skip to main content
Top
Published in: Internal and Emergency Medicine 8/2022

20-07-2022 | Magnetic Resonance Imaging | CE - MEDICAL ILLUSTRATION

A rare case of severe postpartum anti-NMDAR encephalitis

Author: Jia-Qi Chen

Published in: Internal and Emergency Medicine | Issue 8/2022

Login to get access

Excerpt

A 27-year-old woman with abnormal behavior and balderdash was mandatorily hospitalized in the psychiatry department for 1 week. She showed hypochondriac and claimed that she had no brain, no teeth, and believed she was dead, however, had no prior psychiatric history. She was a multiparous woman who had given birth to her second healthy daughter 1 month ago via normal vaginal delivery. Computed tomography (CT) of brain and electroencephalogram (EEG) showed no obvious abnormalities. Therefore, she was diagnosed with Cotard's syndrome and treated with antipsychotic drugs. However, her psychiatric symptoms deteriorated gradually and during treatment, she developed status epilepticus, accompanied by generalized tonic–clonic seizure. Thus, she was immediately transferred to the neurology department of a general hospital. On neurological examination, she lapsed into unconsciousness with fever (38.5 ℃) and only neck stiffness was observed. Subsequently, enhanced magnetic resonance imaging (MRI) of the brain revealed multiple abnormal signals in bilateral cerebral hemispheres, brainstem, and cerebellum but no enhancement (Fig. 1a–d). Meanwhile, cervical MRI indicated abnormal signals in cervical spinal cord (Fig. 1e). In addition, re-examination of EEG suggested a severe abnormality. Therefore, encephalitis was highly suspected and lumbar puncture was carried out instantly. Cerebrospinal fluid (CSF) revealed 1 leucocyte/μl (reference value: < 10 leucocytes/μl), total protein 0.284 g/l (reference value: 0.150–0.450 g/l). Laboratory tests for herpes virus, cytomegalovirus, bacteria, acid-fast bacilli, cryptococcosis, and human immunodeficiency virus were all negative, but with autoimmune encephalitis antibody-associated being positive. The anti-NMDAR antibodies titers of CSF and serum were 1:32 and 1:320, respectively (reference value: negative). Taken together, the patient is definitively diagnosed anti-NMDAR encephalitis and treated with intravenous immunoglobulin (IV-Ig) at the dosage of 0.4 g/kg per day for five consecutive days and intravenous methylprednisolone 1000 mg daily. Considering that anti-NMDAR encephalitis was frequently associated with ovarian teratoma, transvaginal ultrasonography detection was arranged promptly, which showed a strong echo, so teratoma in the left ovary is highly suspected, which is with clear boundary and has no obvious blood flow signal. She underwent laparoscopic removal of the ovarian tumor. Finally, the pathological examination confirmed a mature cystic teratoma (Fig. 1f). Nevertheless, the patient’s condition did not improve despite receiving 2-week aggressive treatment. Whereafter, plasma exchange was implemented to help eliminate pathogenic factors and rituximab was added to the therapeutic regimen. However, her condition continued to deteriorate and she died of multiple organ failure unfortunately.
Literature
Metadata
Title
A rare case of severe postpartum anti-NMDAR encephalitis
Author
Jia-Qi Chen
Publication date
20-07-2022
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 8/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-022-03051-4

Other articles of this Issue 8/2022

Internal and Emergency Medicine 8/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.